SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
41.99
-0.45 (-1.06%)
Jun 11, 2025, 4:00 PM - Market closed
XPH Holdings List
As of Jun 10, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ELAN | Elanco Animal Health Incorporated | 5.29% |
2 | CORT | Corcept Therapeutics Incorporated | 5.05% |
3 | ZTS | Zoetis Inc. | 3.98% |
4 | RPRX | Royalty Pharma plc | 3.93% |
5 | PRGO | Perrigo Company plc | 3.86% |
6 | PBH | Prestige Consumer Healthcare Inc. | 3.79% |
7 | LLY | Eli Lilly and Company | 3.78% |
8 | VTRS | Viatris Inc. | 3.76% |
9 | JNJ | Johnson & Johnson | 3.70% |
10 | PFE | Pfizer Inc. | 3.64% |
11 | AXSM | Axsome Therapeutics, Inc. | 3.54% |
12 | MRK | Merck & Co., Inc. | 3.35% |
13 | JAZZ | Jazz Pharmaceuticals plc | 3.24% |
14 | BMY | Bristol-Myers Squibb Company | 3.21% |
15 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20% |
16 | HRMY | Harmony Biosciences Holdings, Inc. | 3.19% |
17 | PCRX | Pacira BioSciences, Inc. | 2.96% |
18 | AMPH | Amphastar Pharmaceuticals, Inc. | 2.58% |
19 | OGN | Organon & Co. | 2.57% |
20 | ARVN | Arvinas, Inc. | 2.32% |
21 | EWTX | Edgewise Therapeutics, Inc. | 2.23% |
22 | HROW | Harrow, Inc. | 2.20% |
23 | SUPN | Supernus Pharmaceuticals, Inc. | 2.13% |
24 | ANIP | ANI Pharmaceuticals, Inc. | 1.87% |
25 | LGND | Ligand Pharmaceuticals Incorporated | 1.86% |
26 | COLL | Collegium Pharmaceutical, Inc. | 1.82% |
27 | INVA | Innoviva, Inc. | 1.79% |
28 | LQDA | Liquidia Corporation | 1.74% |
29 | CRMD | CorMedix Inc. | 1.70% |
30 | AMRX | Amneal Pharmaceuticals, Inc. | 1.28% |
31 | MNMD | Mind Medicine (MindMed) Inc. | 1.28% |
32 | OCUL | Ocular Therapeutix, Inc. | 1.16% |
33 | WVE | Wave Life Sciences Ltd. | 1.12% |
34 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.04% |
35 | NUVB | Nuvation Bio Inc. | 0.94% |
36 | EOLS | Evolus, Inc. | 0.86% |
37 | XERS | Xeris Biopharma Holdings, Inc. | 0.81% |
38 | ELVN | Enliven Therapeutics, Inc. | 0.69% |
39 | PAHC | Phibro Animal Health Corporation | 0.62% |
40 | ESPR | Esperion Therapeutics, Inc. | 0.58% |
41 | ZVRA | Zevra Therapeutics, Inc. | 0.57% |
42 | OMER | Omeros Corporation | 0.40% |
43 | - | SSI US GOV MONEY MARKET CLASS | 0.23% |
As of Jun 10, 2025